Introduction
Esophageal cancer is a highly aggressive malignancy in digestive tract with high incidence (Parkin et al., 2001-1) and low survival rate (Parkin et al., 2001-2) . It is divided into esophageal adenocarcinoma (EA) and esophageal squamous cell carcinoma (ESCC) according to pathological features. More than 90% of esophageal cancers are ESCC (Parkin et al., 2001-1) . ESCC mainly appears as chronic inflammation, acute abnormality, carcinoma in situ and invasive carcinoma, with a gradual evolution (Kuwano et al., 1993; Zhang et al., 2009 ). At present, ESCC in the majority of patients is diagnosised as advanced metastatic cancer of which the 5-year survival rate is less than 10% (Zhang et al., 2004) . Therefore, it is of great importance to find metastasis-related genes for diagnosing ESCC.
Ning Li, Xiao-Jing Tie, Pei-Jie Liu, Yan Zhang, Hong-Zheng Ren, Xin Gao, Zhi-Qiao Xu* Histone deacetylase 6 (HDAC6), as an important member in the type-II histone deacetylase family, plays an important role in the occurrence and development of tumor. It has become a useful molecular target for malignancy treatment (Carew et al., 2008) . The high expression of HDAC6 has been found in glioma (Wu et al., 2010) , breast cancer (Rey et al., 2010) , lung cancer (Kakihana et al., 2009) , prostate cancer (Ai et al., 2009) , multiple myeloma (Hideshima et al., 2005) , oral squamous cell carcinoma (Sakuma et al., 2006) and other tumors. Researchs have found that HDAC6 is closely related with the occurrence and development of tumor (Duong et al., 2008; Shen et al., 2008) .
There is no report about HDAC6 in ESCC until now. In this paper, the interference of HDAC6 interfering RNA (siRNA) on HDAC6 mRNA and protein expression in EC9706 cells was studied. Effects of down-regulation of HDAC6 expression on cell proliferation, cell cycle and cell migration were investigated, and the related molecular mechanisms were explored. The objective of this study is to clarify the possible role of HDAC6 in ESCC and provide a theoretical basis for treatment of ESCC with HDAC6 as a target.
Materials and Methods

Cell culture and transfection
ESCC cell line EC9706 cells were purchased from the cell bank of Shanghai Institute of Cell Institute, Chinese Academy of Sciences. They were randomly divided into the untreated group, the control siRNA group and the HDAC6 siRNA group. EC9706 cells in the control siRNA group and the HDAC6 siRNA group were transfected with control siRNA and HDAC6 siRNA using Lipofetmiane 2000, respectively.
Detection of HDAC6 mRNA expression by semiquantitative RT-PCR method
After transfection with HDAC6 siRNA for 24 h, Total RNA of EC9706 cells in three groups was extracted using Trizol. The expression of HDAC6 mRNA was detected by RT-PCR method.
Detection of HDAC6 protein expression by Western blotting method
The whole procedure was in accordance with the standard procedure of Western Blotting Method.
Detection of HDAC6 protein expression by immunocytochemistry method
The whole procedure was in accordance with the standard procedure of Immunocytochemistry Method introduced by many researchers He et al., 2006; Yuan et al., 2006; Zhang et al., 2008) .
Detection of cell proliferation by CCK-8 kit
EC9706 cells in three groups were collected 24, 48, 72 and 96h after transfection, respectively. The cell counting was conducted using CCK-8 kit to detect the proliferation of EC9706 cells. The targeted cells were collected in 0, 24, 48, 72 and 96 hr to make the concentration of 2000 cells/100 ul in every hole. The rest procedure was in accordance with the standard procedure of cell proliferation method.
Detection of cell cycle by flow cytometry
EC9706 cells (1×10 6 per group) were collected in 48h and trypsinized with 0.2 % trypsin. After centrifuged 1000 rpm for 5 min, the residue was then washed twice with PBS and solidated with 70% icy ethanol for 30 min and stored in 4 ℃ for the whole night. The cell cycle was then detected with flow cytometry.
Detection of cell migration by Boyden chamber
The migration of EC9706 cells was determined by the boyden chamber assay. The sum of cells in 5 fields of high power lens was averaged for the index of Tumorocellular infiltration ability.
Detection of p21 and E-cadherin mRNA expression by semi-quantitative RT-PCR method
The procedure was in accordance with those of Semi-Quantitative RT-PCR method, while the annealing temperature was set as 62℃ for p21 gene and 52℃ for E-cadherin gene, respectively.
Detection of p21 and E-cadherin protein expression by Western blotting method
The procedure was in accordance with those of Western blotting method.
Statistical analysis
Data were expressed as mean ± SD. Statistical analysis was performed using SPSS 13.0 statistical software. A t-test was used to analyze the differences between two groups. A One-way ANOVA was performed to analyze the differences in three groups. P < 0.05 was considered as statistically significant.
Results
Expression of HDAC6 mRNA in EC9706 cells
After transfection, the expression of HDAC6 mRNA in EC9706 cells was detected by semi-quantitative RT-PCR method. Results were shown in Figure 1 . The expression of HDAC6 mRNA in the HDAC6 siRNA group (0.044) was significantly reduced compared to the untreated group (0.951) and the control siRNA group (0.947) (P < 0.05), respectively. There was no significant difference between the control siRNA group and the untreated group (P>0.05). This indicated that HDAC6 siRNA could effectively downregulate the expression of HDAC6 mRNA in EC9706 cells. 
Expression of HDAC6 protein in EC9706 cells
The expression of HDAC6 protein in EC9706 cells was detected by Western blotting and immunocytochemistry methods, respectively. As shown in Figure 2 , the expression level of HDAC6 protein in HDAC6 siRNA group (0.114) was significantly lower than that in the untreated group (0.924) and the control siRNA group (0.905) (P<0.05), respectively. There was no significant difference between the later two groups (P > 0.05). Results of immunocytochemistry detection showed that the HDAC6 protein was mainly localized in the cytoplasm. There was a strong expression of HDAC6 protein in the untreated group and the control siRNA group, and the expression level in the HDAC6 siRNA group was very low. HDAC6 siRNA could also effectively downregulate the expression of HDAC6 protein in EC9706 cells.
Effects of down-regulation of HDAC6 expression on proliferation of EC9706 cells
The proliferation of EC9706 cells was detected using CCK-8 kit. Results were shown in Figure 3 . There was no significant difference of EC9706 cell proliferation between the control siRNA group and the untreated group (P>0.05). The cell proliferation in the HDAC6 siRNA group was significantly reduced compared to the untreated group and the control siRNA group (P<0.05), respectively. This indicated that the down-regulation of HDAC6 expression could effectively inhibit the proliferation of EC9706 cells.
Effects of down-regulation of HDAC6 expression on cell cycle of EC9706 cells
The cell cycle of EC9706 cells was detected by flow cytometry. The percentage of EC9706 cells in G0/ G1 phase in the HDAC6 siRNA group (68.55±2.01%) was significantly higher than that in the untreated group (45.64±1.26%) and the control siRNA group (46.23±1.39%) (P<0.05), respectively. There was no significant difference between the untreated group and the control siRNA group (P > 0.05). In addition, the percentage of cells in S phase in the HDAC6 siRNA group (25.93±0.73%) was significantly lower than that in the untreated group (33.13±1.02%) and the control siRNA group (32.98±0.91%) (P<0.05), respectively. Downregulation of HDAC6 expression could induce the cell cycle of EC9706 cell to arrest in G0/G1 phase and might prevent its DNA synthesis.
Effects of down-regulation of HDAC6 expression on migration of EC9706 cells
The migration of EC9706 cells was detected by Boyden chamber. Results were shown in Figure 4 . The number of migrated EC9706 cells in the HDAC6 siRNA group (55.96±3.98) was significantly less than that in the untreated group (134.32±6.71) and the control siRNA group (127.85±7.12) (F=152.614, P>0.000), respectively. There was no significant difference between the untreated group and the control siRNA group (P>0.05). This indicated that down-regulation of HDAC6 expression can effectively inhibit the migration of EC9706 cells.
Expression of p21 and E-cadherin mRNA and protein mediated by HDAC6 siRNA
In order to further explore the mechanisms of cell cycle quiescence and migration reduction mediated by HDAC6 siRNA, the mRNA and protein expression of p21 and E-cadherin in EC9706 cells were detected by semi-quantitative RT-PCR and Western blotting methods. Results were shown in Figure 5 and 6. The mRNA and protein expression levels of p21 and E-cadherin in the HDAC6 siRNA group were significantly higher than that in the untreated group and the control siRNA group (P<0.05), respectively. There was no significant difference between the later two groups (P>0.05). This indicated that the cell cycle quiescence and migration reduction of EC9706 cells mediated by HDAC6 siRNA might be closely related with the elevation of the mRNA and protein expression levels of p21 and E-cadherin RNA.
Discussion
It is well known that the occurrence and development of tumors were bidirectionally regulated by the genetic modification and the epigenetic modification. The recent rising epigenetics plays a vital role in the occurrence and development of disease. Abnormal epigenetic regulatory mechanisms in body will lead to a variety of diseases including cancer and metabolic, genetic, immune, inflammatory, infectious, cardiovascular diseases. Epigenetics can not only deeply explore the mechanisms of various diseases, but also find the warning molecules and preventive target molecules of disease. It plays a significant role in the treatment and prevention of disease. With the publication of human epigenetics maps and development of epigenetic detection technology, there will be a greater progress of epigenetics in the next 10 years. It has been concluded for a long time that the gene mutation is involved in the tumor formation, but in recent years more and more evidences show that epigenetic modification also plays a very important role in tumor progression Unoki et al., 2011) . Epigenetic regulation can affect the gene transcription and do not change the DNA sequence. It includes DNA methylation and modifications of chromosomal histone such as methylation, acetylation, phosphorylation, ubiquitination, etc (Banerjee et al., 2009) .
HDAC6 is a unique histone deacetylase locating at the cytoplasm. It is combinated with the microtubules as a α-tubulin deacetylase. It is found that a lot of protein can be acetylated, and HDAC6 plays an important role in the physiological and pathological processes such as transcriptional regulation, signal transduction, cell differentiation and apoptosis, growth and development, and occurrence of metabolic diseases and tumors (Barnes et al., 2009; Husain et al., 2009; Carter et al., 2010) . Researchs show that HDAC6 can be regarded as the target for cancer treatment (Barnes et al., 2009) , and histone deacetylase inhibitor (HDACi) can induce the cell apoptosis in cancer (Jiang et al., 2009; Shen et al., 2011) . But so far the research on HDAC6 in ESCC is seldom reported.
The current rising RNA interference is one of the ideal technical means of studying the gene function in vivo and in vitro. It has been used in disease treatment and biological labeling (Baker et al., 2010 ) with a good prospects. Many studies show that the RNA interference plays an important role in inhibiting cancer gene over-expression (Xu et al., 2011) . It may be a new means in cancer treatment. In this study, the interference of HDAC6 siRNA on HDAC6 expression in EC9706 cells is investigated. Results show that HDAC6 siRNA could effectively downregulate the expression of HDAC6 mRNA and protein in EC9706 cells. It has provided a theoretical basis for further studying the function of HDAC6 in ESCC.
Increase of HDAC expression level can accelerate proliferation of tumor cell, reduce cell apoptosis, alter cell cycle, promote tumor angiogenesis formation and induce cancer gene expression. HDAC is over-expressed in many tumor cells, which results in expression inhibition of many important growth inhibiting genes. This is an important mechanism of HDAC promoting tumor cell proliferation. It is found that the over-expression of HDAC is closely related the decrease of p21 expression (Hrzenjak et al., 2006) . Over-expression of HDAC3 in colon cancer cells can lead to the inhibition of p21 expression, and HDAC3 quiescence can promote the expression of p21 (Wilson et al., 2006) . In addition, HDAC6 is expressed in the differentiated pre-osteoblasts, and it can interact with the transcription factor Runx2 to regulate the p21 expression (Westendorf et al., 2002) . Results of our study show that down-regulation of HDAC6 expression can effectively inhibit the proliferation of EC9706 cells, arrest cell cycle at G0/G1 phase, and prevent the synthesis of DNA. Further study on expression of cell cycle related factor p21 shows that, after transfection with HDAC6 siRNA, the mRNA and protein expression levels of p21 in EC9706 cells significantly increase. This indicated that the cell cycle quiescence and migration reduction of EC9706 cells mediated by HDAC6 siRNA may be closely related with the elevation of p21expression. HDAC6 is a kind of multifunctional protein. It can regulate many different biological processes including cell migration, protein folding, misfolding protein degradation, cell stress and immunological synapse formation (Kawaguchi et al., 2003) . A lot of studies find that down-regulation of HDAC6 expression can reduce the cell migration. Whether down-regulation of HDAC6 expression can reduce the migration of ESCC it is still unknown. In Our study, the migration of EC9706 cells is detected by Boyden chamber. Results show that down-regulation of HDAC6 expression can effectively inhibit the migration of EC9706 cells. E-cadherin is a glycoprotein with extracellular domain which interacts with neighboring E-cadherin molecular to create connections between epithelial cells. The function reduction and expression loss of E-cadherin may lead to the damage of cell connections which is closely related to the tumor cell invasion and metastasis (Zhang et al., 2012) . It is found that inhibition of HDAC6 activity could significantly upregulate the E-cadherin expression (Rey et al., 2010) . Our study shows that, after transfected with HDAC6 siRNA, the E-cadherin expression level in EC9706 cells significantly increases. This indicates that the migration reduction of EC9706 cells mediated by down-regulation of HDAC6 expression may be closely related with the rise of E-cadherin expression level, but the specific molecular mechanisms need to be further explored.
In conclusions, HDAC6 siRNA can effectively downregulate the expression of HDAC6 mRNA and protein in EC9706 cells. The down-regulation of HDAC6 expression caould obviously inhibit the cell proliferation of EC9706, inducing the cell cycle quiescence, and reduce the cell migration. These may be closely related with the rising expression levels of p21 and E-cadherin.
